Both in Pharmaceuticals
Cadrenal Therapeutics vs Onconetix
Over the past year CVKD returned −91.6% and ONCO returned −99.6%; their daily moves had a correlation of 0.03.
CVKD −91.6% ONCO −99.6%Growth of $1, one year, split-adjusted
| Metric | CVKD | ONCO |
|---|---|---|
| Price | $1.13 | $0.5690 |
| Market cap | $4.0M | $3.3M |
| Today | +8.65% | +4.83% |
| 1 month | +19.5% | −15.5% |
| 6 months | −82.1% | −89.1% |
| Year to date | −83.3% | −99.3% |
| 1 year | −91.7% | −99.7% |
| Revenue growth (YoY) | — | −83.9% |
| Gross margin | — | 25.1% |
| Net margin | — | −16748.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.2× |
| Net cash | $2.4M | $5.8M |
| Dividend yield | — | — |
| Volatility (60d) | 89.6% | 157.5% |
| Short % of float | 9.2% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).